Hormone replacement therapy and risk of pancreatic cancer in postmenopausal women: Evidence from the US National Inpatient Sample 2008-2018
View abstract on PubMed
Summary
This summary is machine-generated.Hormone replacement therapy (HRT) may reduce pancreatic cancer risk in postmenopausal women. This study found HRT associated with significantly decreased odds of pancreatic cancer, particularly in women aged 55-74.
Area Of Science
- Oncology
- Endocrinology
- Epidemiology
Background
- Pancreatic cancer is an aggressive malignancy with high mortality.
- Previous research on hormone replacement therapy (HRT) and pancreatic cancer risk has produced conflicting results.
- This study investigates the association between HRT and pancreatic cancer risk in postmenopausal women.
Purpose Of The Study
- To determine if HRT use is associated with a reduced risk of pancreatic cancer in postmenopausal women.
- To analyze the association in different age groups and among women with specific health conditions.
Main Methods
- A population-based, retrospective study using data from the US National Inpatient Sample (NIS) from 2008-2018.
- Inclusion criteria: hospitalized females aged 55 years and older.
- Univariate and multivariable regression analyses were performed to assess associations between HRT and pancreatic cancer diagnosis.
Main Results
- The analysis included 35,309 women using HRT and 141,236 women not using HRT, matched by age.
- Multivariable analyses revealed that HRT use was significantly associated with decreased odds of pancreatic cancer (adjusted OR, 0.69).
- Reduced odds of pancreatic cancer were observed in women aged 55-74 using HRT, as well as in non-hypertensive and non-hyperlipidemic groups.
Conclusions
- Hormone replacement therapy (HRT) is associated with a reduced risk of pancreatic cancer in US postmenopausal women.
- The protective association appears stronger in women aged 55-74.
- Further research is warranted to elucidate the underlying biological mechanisms responsible for this observed association.
Related Concept Videos
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Detailed History: Understanding the patient's symptoms is critical. It includes inquiring about abdominal pain, weight loss, and digestive issues, which are common in chronic pancreatitis.
Physical Examination: This might reveal abdominal tenderness, jaundice, and signs of malnutrition,...
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

